Bullseye Asset Management LLC Axonics, Inc. Transaction History

Bullseye Asset Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$47.99 - $60.21 $164,653 - $206,580	3,431 Added 9.03%	41,425 $2.09 Million
Q3 2022 Nov 14, 2022	SELL	$57.96 - $78.12 $26,024 - $35,075	-449 Reduced 1.17%	37,994 $2.68 Million
Q2 2022 Aug 15, 2022	BUY	$39.5 - $64.42 $1,580 - $2,576	40 Added 0.1%	38,443 $2.18 Million
Q3 2021 Nov 15, 2021	SELL	$59.21 - $78.66 $6,098 - $8,101	-103 Reduced 0.27%	38,403 $2.5 Million
Q4 2020 Feb 12, 2021	SELL	$42.19 - $51.5 $13,247 - $16,171	-314 Reduced 0.81%	38,506 $1.92 Million
Q3 2020 Nov 12, 2020	SELL	$35.33 - $51.04 $812 - $1,173	-23 Reduced 0.06%	38,820 $1.98 Million
Q2 2020 Aug 11, 2020	BUY	$22.91 - $39.83 $231,711 - $402,840	10,114 Added 35.2%	38,843 $1.36 Million
Q1 2020 May 08, 2020	SELL	$16.44 - $37.73 $3,435 - $7,885	-209 Reduced 0.72%	28,729 $730,000
Q4 2019 Feb 18, 2020	BUY	$19.57 - $28.96 $566,316 - $838,044	28,938 New	28,938 $802,000

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Bullseye Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bullseye Asset Management LLC with notifications on news.